Enhancement of antibody-dependent cytotoxicity with a chimeric anti-GD2 antibody - PubMed (original) (raw)
. 1990 Feb 15;144(4):1382-6.
Affiliations
- PMID: 2303711
Enhancement of antibody-dependent cytotoxicity with a chimeric anti-GD2 antibody
B M Mueller et al. J Immunol. 1990.
Abstract
A mouse/human chimeric antibody (ch14.18) was developed that reacts with the disialoganglioside GD2 on the surface of tumor cells of neuroectodermal origin. ch14.18 has the constant regions of a human IgG1 antibody and was expressed in a murine hybridoma. This antibody was produced in tissue culture at concentrations up to 180 mg/liter of spent culture fluid. ch14.18 was characterized and compared to 14.G2a, a murine mAb against GD2 of IgG2a isotype derived from the same parental hybridoma as ch14.18. Scatchard plot analysis of data from saturation binding studies on M21 melanoma cells showed identical binding for ch14.18 and 14.G2a. Indirect immunofluorescence revealed the same staining pattern for ch14.18 and 14.G2a on different melanoma cell lines. Both antibodies were equally capable of targeting M21 xenografts in athymic nude mice. ch14.18- and 14.G2a-activated human C-mediated cytolysis of melanoma cell; however, ch14.18-mediated antibody-dependent cytotoxicity of human effector cells against melanoma cells 50- to 100-fold more efficiently than 14.G2a.
Similar articles
- Effect of a chimeric anti-ganglioside GD2 antibody on cell-mediated lysis of human neuroblastoma cells.
Barker E, Mueller BM, Handgretinger R, Herter M, Yu AL, Reisfeld RA. Barker E, et al. Cancer Res. 1991 Jan 1;51(1):144-9. Cancer Res. 1991. PMID: 1988079 - Anti-neuroblastoma effect of ch14.18 antibody produced in CHO cells is mediated by NK-cells in mice.
Zeng Y, Fest S, Kunert R, Katinger H, Pistoia V, Michon J, Lewis G, Ladenstein R, Lode HN. Zeng Y, et al. Mol Immunol. 2005 Jul;42(11):1311-9. doi: 10.1016/j.molimm.2004.12.018. Epub 2005 Apr 7. Mol Immunol. 2005. PMID: 15950727 - Activation of human effector cells by a tumor reactive recombinant anti-ganglioside GD2 interleukin-2 fusion protein (ch14.18-IL2).
Hank JA, Surfus JE, Gan J, Jaeger P, Gillies SD, Reisfeld RA, Sondel PM. Hank JA, et al. Clin Cancer Res. 1996 Dec;2(12):1951-9. Clin Cancer Res. 1996. PMID: 9816154 - Combination therapy with interleukin-2 and antitumor monoclonal antibodies.
Sondel PM, Hank JA. Sondel PM, et al. Cancer J Sci Am. 1997 Dec;3 Suppl 1:S121-7. Cancer J Sci Am. 1997. PMID: 9457407 Review. - Dinutuximab: first global approval.
Dhillon S. Dhillon S. Drugs. 2015 May;75(8):923-7. doi: 10.1007/s40265-015-0399-5. Drugs. 2015. PMID: 25940913 Review.
Cited by
- GD2-targeting therapy: a comparative analysis of approaches and promising directions.
Philippova J, Shevchenko J, Sennikov S. Philippova J, et al. Front Immunol. 2024 Mar 15;15:1371345. doi: 10.3389/fimmu.2024.1371345. eCollection 2024. Front Immunol. 2024. PMID: 38558810 Free PMC article. Review. - Advances in new targets for immunotherapy of small cell lung cancer.
Zheng Z, Liu J, Ma J, Kang R, Liu Z, Yu J. Zheng Z, et al. Thorac Cancer. 2024 Jan;15(1):3-14. doi: 10.1111/1759-7714.15178. Epub 2023 Dec 13. Thorac Cancer. 2024. PMID: 38093497 Free PMC article. Review. - A Multi-Color Flow Cytometric Assay for Quantifying Dinutuximab Binding to Neuroblastoma Cells in Tumor, Bone Marrow, and Blood.
Keyel ME, Furr KL, Kang MH, Reynolds CP. Keyel ME, et al. J Clin Med. 2023 Sep 27;12(19):6223. doi: 10.3390/jcm12196223. J Clin Med. 2023. PMID: 37834874 Free PMC article. - Biology of GD2 ganglioside: implications for cancer immunotherapy.
Machy P, Mortier E, Birklé S. Machy P, et al. Front Pharmacol. 2023 Aug 21;14:1249929. doi: 10.3389/fphar.2023.1249929. eCollection 2023. Front Pharmacol. 2023. PMID: 37670947 Free PMC article. Review. - Aberrant Glycosylation as Immune Therapeutic Targets for Solid Tumors.
Matsumoto Y, Ju T. Matsumoto Y, et al. Cancers (Basel). 2023 Jul 8;15(14):3536. doi: 10.3390/cancers15143536. Cancers (Basel). 2023. PMID: 37509200 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources